America Great Health (AAGH) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US02365T1016

Price
0.00 USD
Market cap
4.23 m USD
P/E (2026)
–
P/S (2026)
10.79
Dividend yield
0.00 %
Net margin
-184.11 %
Return on equity (ROE)
12.56 %
Return on assets (ROA)
-238.97 %

America Great Health financials

Fiscal year20252026
Revenue294,670.00 USD391,743.00 USD
Gross profit169,750.00 USD339,121.00 USD
Operating income-782,700.00 USD-382,935.00 USD
EBIT-382,935.00 USD–
Net income-1.22 m USD-721,242.00 USD
Diluted EPS – continuing operations0.00 USD–

Full history since 2011, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About America Great Health

America Great Health operates as a biotechnology company in the United States. The company focuses on the research and development of protein and peptide small molecular drugs; and manufacture and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and re-generational medicine and supplements. The company was formerly known as Crown Marketing and changed its name to America Great Health in March 2017. America Great Health is based in Alhambra, California.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.